“biovex” Archives

Entry Author Date Location
Oncorus Bags $57M, Touts Next-Gen Take on Cancer-Fighting Viruses 07/19/16 Boston
West Coast Biotech Roundup: Mapp Bio, Calico, Alder, VentiRx & More 09/04/14 San Diego
Assigning Credit and Blame to Biopharma R&D Chiefs 05/29/13 Seattle
Biotech VCs, in Shadow of Tech, Start Delivering More Hits 07/19/12 National
Amira Pharma on How it Beat the Odds, and Sold an Early Stage Drug to Bristol-Myers for $325M 09/07/11 San Diego
Jennerex Shows that Unorthodox Cancer-Fighting Virus Can be Delivered the Usual Way 08/31/11 San Francisco
Stop the M&A Obsession: Biotech Needs More Companies to Stay Independent 07/18/11 National
Jennerex Shows Survival Edge for Liver Cancer Patients in Small Study of Anti-Tumor Virus 05/19/11 San Francisco
The Resurgence of Gene and Cell Therapy 05/16/11 Seattle
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the First Quarter 03/31/11 Boston
Jennerex, Maker of Cancer-Fighting Virus, Says Early Data Shows Survival Benefit 02/17/11 San Francisco
Clinical Data Stock Soars on FDA Approval, Amgen Buys BioVex, Stromedix Raises $2M, & More Boston-Area Life Sciences News 01/28/11 Boston
Seattle Genetics Manager Accused of Insider Trading, Bristol Stays in Seattle, Amgen Buys BioVex, & More Seattle-Area Life Sciences News 01/27/11 Seattle
Amgen’s R&D Chief, Roger Perlmutter, on Why BioVex’s Cancer-Fighting Virus Is Worth $1B 01/26/11 Boston
Myriant Gets $60M, BioVex Bought By Amgen, Raindance Wraps Up $37.5M, & More Boston-Area Deals News 01/26/11 Boston
Amgen Acquires BioVex for $1,000,000,000 01/25/11 Boston
Amgen to Acquire BioVex for Up To $1B, to Obtain Cancer-Killing Virus Therapy 01/24/11 Boston
Jennerex, Charging Ahead With Tumor-Killing Virus, Follows Biotech Road Less Traveled 09/09/10 San Francisco
2009’s Top 10 Private Equity Deals in Massachusetts: The List 01/25/10 Boston
Bay State Venture Funding Perked Up in November: There Were Even Some Energy Deals 12/11/09 Boston
Pulmatrix Pulls in $30.2M, GenArts Gobbles Up Wondertouch, BioVex Bags $30M, & More Boston-Area Deals News 11/11/09 Boston
BioVex Nails Down Another $30M To Finish Pivotal Study of Cancer-Killing Virus 11/10/09 Boston
BioVex Garners $30,000,000 Series F Funding 11/10/09 Boston
Lilliputian Discovers $25M, Biovex Bags $40M, Clinical Data Cedes Cogenics to Beckman Coulter for $17M, & More Boston-Area Deals News 04/06/09 Boston
Genzyme Shrinks Gene Therapy Effort, Expands Oncology; BioVex Raises $40M For Cancer-Fighting Viruses; Biogen Looks to Future of MS Franchise; & More Boston-Area Life Sciences News 04/01/09 Boston
BioVex Raises $40M for Cancer-Fighting Virus 03/30/09 Boston
Boston Biotechs Seek Scarce Funds Amid Market Famine at Annual Pitch Event 12/04/08 Boston
BioVex Viral Treatment Shrinks Melanoma Tumors in Trial 06/01/08 Boston
Pfizer Picks a Local Target, Sermo Meets Satellite Radio, and the Rest of the Recent Deals 11/19/07 Boston
BioVex Completes $35 Million Financing 11/16/07 Boston
Page 1 of 1